Kneat Announces Record Revenue for First Quarter 2024
LIMERICK,
- First-quarter 2024 total revenue reaches
$10.8 million , an increase of 35% year over year - Annual Recurring Revenue (ARR)1 at
March 31, 2024 grows 57% year over year, to$42.1 million - SaaS ARR1 at
March 31, 2024 reaches$41.8 million , an increase of 59% year over year
“Kneat is off to a solid start to what we expect to be another excellent year. Thousands of new licenses went to customers in the quarter, as many extended Kneat Gx to more sites and processes, and as new customers were added. Our pipeline is as strong as ever, after expanding and developing our sales team. And our team is making strides building Kneat Gx to make it the gold standard across all validation use cases for life science.”
-said
Q1 2024 Highlights
- Total revenues increased 35% to
$10.8 million in the first quarter of 2024, compared to$8.0 million for the first quarter of 2023. - SaaS revenue for the first quarter of 2024 grew 52% to
$9.7 million , versus$6.4 million for the first quarter of 2023. - First-quarter 2024 gross profit was
$7.9 million , up 48% from$5.4 million in gross profit for the first quarter of 2023. - Gross margin in the first quarter of 2024 was 74%, compared to 67% for the first quarter of 2023.
- EBITDA1 in the first quarter of 2024 was
($0.5) million , compared with($0.6) million for the first quarter of 2023. - Adjusted EBITDA1 in the first quarter of 2024 was
$0.6 million , compared with($1.1) million for the first quarter of 2023. - Net loss for the first quarter of 2024 was
($3.3) million , compared with($2.5) million for the first quarter of 2023. - Total ARR1, which includes SaaS license and recurring maintenance fees, was
$42.1 million atMarch 31, 2024 , an increase of 57% from$26.9 million atMarch 31, 2023 . - SaaS ARR1, the proportion of ARR attributable to SaaS licenses, was
$41.8 million at the end of the first quarter of 2024, an increase of 59% from$26.3 million atMarch 31, 2023 . - In
January 2024 , Kneat announced that it signed a three-year Master Services Agreement with a global manufacturer of consumer health and wellness products. Headquartered inEurope , with over 35,000 employees and operations in more than 50 countries, the company's goal is to digitize and harmonize their equipment and computer systems validation processes across theirNorth America , European and theAsia-Pacific manufacturing sites. Implementation is ongoing at lead sites in theUK and the US, with initial go-live expected in Q2 2024. - In
February 2024 , Kneat announced that it signed a Master Services Agreement with a global provider of critical care products. Headquartered inthe United States , with over 50,000 employees and operations in more than 20 countries, the company will leverage Kneat Gx beginning with its equipment validation processes. Implementation has begun at its lead site, and will follow at two additional sites, with initial go-live expected in Q3 2024. - Also in
February 2024 , Kneat completed an equity financing through an agreement with a syndicate of investment dealers led byCormark Securities for aggregate gross proceeds of approximately$20 million in exchange for 6,153,880 common shares from the treasury of the Company.
“With our recent financing and solid performance in the first quarter, we are in a strong financial position to continue doing what we do best, that is, executing on our growth strategy.”
-said
Quarterly Conference Call
Interested parties can register for the live webcast via the following link:
Supplementary and Non-IFRS Financial Measures
The Company uses supplementary financial measures as key performance indicators in its MD&A and other communications. Management uses both IFRS measures and supplementary, non-IFRS financial measures as key performance indicators when planning, monitoring and evaluating the Company’s performance.
Annual Recurring Revenue (“ARR”)
ARR is used by Kneat to assess the expected recurring annual revenues from the customers that are live on the Kneat Gx platform at the end of the period. ARR is calculated using the licenses delivered to customers at the period end, multiplied by the expected customer retention rate of 100% and multiplied by the full agreed annual SaaS license or maintenance fee. Since many of the customer contracts are in currencies other than the Canadian dollar, the Canadian dollar equivalent is calculated using the related period end exchange rate multiplied by the contracted currency amount.
Software-as-a-Service Annual Recurring Revenue (“SaaS ARR”)
SaaS ARR is a component of ARR that is used by Kneat to assess the expected recurring revenues exclusively from license subscriptions to the Kneat Gx platform at the end of the period. SaaS ARR is calculated as the SaaS licenses delivered to customers at the period end, multiplied by the expected customer retention rate of 100% and multiplied by the full agreed SaaS license fee. Since many of the customer contracts are in currencies other than the Canadian dollar, the Canadian dollar equivalent is calculated using the related period end exchange rate multiplied by the contracted currency amount.
Earnings before Interest, Taxes, Depreciation and Amortization (“EBITDA”)
EBITDA is calculated as net income (loss) attributable to
Adjusted Earnings before Interest, Taxes, Depreciation and Amortization (“Adjusted EBITDA”)
Adjusted EBITDA is calculated as net income (loss) attributable to
About Kneat
Kneat Solutions provides leading companies in highly regulated industries with unparalleled efficiency in validation and compliance through its digital validation platform Kneat Gx. We lead the industry in customer satisfaction with an unblemished record for implementation, powered by our user-friendly design, expert support, and on-demand training academy. Kneat Gx is an industry-leading digital validation platform that enables highly regulated companies to manage any validation discipline from end-to-end. Kneat Gx is fully ISO 9001 and ISO 27001 certified, fully validated, and 21 CFR Part 11/Annex 11 compliant. Multiple independent customer studies show a 40% or more reduction in validation cycle times, nearly 20% faster speed to market, and 80% reduced changeover time.
Cautionary and Forward-Looking Statements
Except for the statements of historical fact contained herein, certain information presented constitutes "forward-looking information" within the meaning of applicable Canadian securities laws. Such forward-looking information includes, but is not limited to, the relationship between Kneat and the customer, Kneat's business development activities, the use and implementation timelines of Kneat's software within the customer's validation processes, the ability and intent of the customer to scale the use of Kneat's software within the customer's organization, our ability to win business from new customers and expand business from existing customers, our expected use of the net proceeds from the IPF Facility and/or any future offering, the anticipated effects of the IPF Facility and/or any future offering on our business and operations, and the compliance of Kneat's platform under regulatory audit and inspection. These and other assumptions, risks and uncertainties may cause Kneat's actual results, performance, achievements and developments to differ materially from the results, performance, achievements or developments expressed or implied by forward-looking statements.
Material risks and uncertainties relating to our business are described under the headings "Cautionary Note Regarding Forward-Looking Statements and Information" and "Risk Factors" in our annual MD&A dated
For further information:
P: + 1 902-706-9074
E: katie.keita@kneat.com
Unaudited Condensed Interim Consolidated Statements of Loss and Comprehensive Loss | |||||||
(expressed in Canadian dollars) | |||||||
Three-month period ended | |||||||
Revenue | |||||||
SaaS License fees | 9,718,501 | 6,387,635 | |||||
On-premise license fees | - | 436,126 | |||||
Maintenance fees | 70,589 | 151,094 | |||||
Professional services and other | 977,910 | 990,053 | |||||
Total Revenue | 10,767,000 | 7,964,908 | |||||
Cost of Revenue | (2,834,015 | ) | (2,591,609 | ) | |||
Gross Profit | 7,932,985 | 5,373,299 | |||||
Gross Margin | 74 | % | 67 | % | |||
Expenses | |||||||
Research and development | (4,045,548 | ) | (3,863,685 | ) | |||
Sales and marketing | (4,031,684 | ) | (2,954,740 | ) | |||
General and administrative | (2,105,589 | ) | (1,905,882 | ) | |||
Total Expenses | (10,182,821 | ) | (8,724,307 | ) | |||
Operating Loss | (2,249,836 | ) | (3,351,008 | ) | |||
Interest expense | (867,451 | ) | (54,945 | ) | |||
Interest income | 35,076 | 1,933 | |||||
Foreign exchange gain (loss) | (238,763 | ) | 938,213 | ||||
Loss before income taxes | (3,320,974 | ) | (2,465,807 | ) | |||
Income taxes | (15,887 | ) | (8,550 | ) | |||
Net loss for period | (3,336,861 | ) | (2,474,357 | ) | |||
Other comprehensive (loss) / income | |||||||
Foreign currency translation adjustment to presentation currency | 190,894 | (565,416 | ) | ||||
Comprehensive loss for the period | (3,145,967 | ) | (3,039,773 | ) | |||
Loss per share - basic and diluted | $ | (0.04 | ) | $ | (0.03 | ) | |
Weighted Average Number of Common Shares Outstanding | |||||||
Basic and diluted | 81,005,029 | 77,686,689 | |||||
Reconciliation: | |||||||
Total loss for the period | (3,336,861 | ) | (2,474,357 | ) | |||
Interest expense | 867,451 | 54,945 | |||||
Interest income | (35,076 | ) | (1,933 | ) | |||
Income taxes | 15,887 | 8,550 | |||||
Depreciation expense | 191,221 | 203,616 | |||||
Amortization expense | 1,834,211 | 1,564,303 | |||||
EBITDA Loss | (463,167 | ) | (644,876 | ) | |||
Adjustments to EBITDA | |||||||
Foreign exchange loss (gain) | 238,763 | (938,213 | ) | ||||
Stock-based compensation expense | 812,173 | 489,399 | |||||
Adjusted EBITDA Loss | 587,769 | (1,093,690 | ) | ||||
Unaudited Condensed Interim Consolidated Statements of Financial Position | ||||||
(expressed in Canadian dollars) | ||||||
as at | ||||||
2024 | 2023 | |||||
Assets | ||||||
Current assets | ||||||
Cash | 37,507,949 | 15,252,526 | ||||
Accounts receivable | 15,557,613 | 11,601,558 | ||||
Prepayments | 1,100,664 | 1,138,382 | ||||
54,166,226 | 27,992,466 | |||||
Non-current assets | ||||||
Accounts receivable | 2,352,759 | 1,650,795 | ||||
Property and equipment | 6,992,503 | 7,209,953 | ||||
Intangible assets | 29,471,354 | 27,642,752 | ||||
Total assets | 92,982,842 | 64,495,966 | ||||
Liabilities | ||||||
Current liabilities | ||||||
Accounts payable and accrued liabilities | 7,853,756 | 7,874,332 | ||||
Contract liabilities | 25,457,756 | 13,647,071 | ||||
Lease liabilities | 537,305 | 535,832 | ||||
Loan payable | 728,950 | - | ||||
34,577,767 | 22,057,235 | |||||
Non-current liabilities | ||||||
Contract liabilities | 99,891 | 41,084 | ||||
Lease liabilities | 5,810,715 | 5,976,380 | ||||
Loan payable and accrued interest | 21,048,866 | 21,657,423 | ||||
Total Liabilities | 61,537,239 | 49,732,122 | ||||
Equity | ||||||
Shareholders' equity | 31,445,603 | 14,763,844 | ||||
Total liabilities and equity | 92,982,842 | 64,495,966 | ||||
Unaudited Condensed Interim Consolidated Statement of Cash Flows | |||||
(expressed in Canadian dollars) | |||||
For the period ended | |||||
3 months | 3 months | ||||
2024 | 2023 | ||||
Operating activities | |||||
Net loss for the period | (3,336,861 | ) | (2,474,357 | ) | |
Charges to loss not involving cash: | |||||
Depreciation of property and equipment | 191,221 | 203,616 | |||
Share-based compensation expense | 812,173 | 489,399 | |||
Interest expense | 867,451 | 54,945 | |||
Tax expense | 15,887 | 8,550 | |||
Amortization of the intangible asset | 1,834,211 | 1,564,303 | |||
Amortization of loan issuance costs | 36,957 | - | |||
Write-off of property and equipment | - | 764 | |||
Foreign exchange loss/(gain) | 238,763 | (938,213 | ) | ||
Increase/(Decrease) in non-current contract liabilities | 58,319 | (274,257 | ) | ||
Net change in non-cash working capital related to operations | 7,684,397 | 3,968,242 | |||
Net cash provided by operating activities | 8,402,518 | 2,602,992 | |||
Financing activities | |||||
Proceeds received from public equity financing | 20,000,110 | - | |||
Share issuance costs associated with equity financings | (1,626,257 | ) | - | ||
Payment of principal and interest on the loan payable | (621,996 | ) | - | ||
Proceeds from the exercise of stock options | 641,700 | 24,000 | |||
Repayment of lease liabilities | (181,158 | ) | (203,457 | ) | |
Net cash provided by/(used in) financing activities | 18,212,399 | (179,457 | ) | ||
Investing activities | |||||
Additions to the intangible asset | (4,515,850 | ) | (4,099,009 | ) | |
Additions to property and equipment | (8,163 | ) | (11,294 | ) | |
Net cash used in investing activities | (4,524,013 | ) | (4,110,303 | ) | |
Effects of exchange rates on cash | 164,519 | 12,728 | |||
Net change in cash during the period | 22,255,423 | (1,674,040 | ) | ||
Cash - Beginning of period | 15,252,526 | 12,282,478 | |||
Cash - End of period | 37,507,949 | 10,608,438 | |||
______________________
1 ARR and SaaS ARR are supplementary measures. EBITDA and Adjusted EBITDA are non-IFRS measures and are not recognized, defined or standardized measures under IFRS. These measures are defined in the “Supplementary and Non-IFRS Measures” section of this news release.
Source: kneat.com